US Patent 9163076 Human skin equivalents expressing exogenous polypeptides

Patent 9163076 was granted and assigned to Stratatech Corporation on October, 2015 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

Stratatech Corporation

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

9163076

Date of Patent

October 20, 2015

Patent Application Number

11365357

Date Filed

March 1, 2006

Patent Primary Examiner

‌

Christopher M Babic

Patent abstract

The present invention relates generally to compositions for wound healing. More specifically, the present invention provides human skin equivalents engineered to express exogenous proteinase inhibitor polypeptides (e.g., TIMP-1 polypeptides) and compositions and methods for making human skin equivalents engineered to express exogenous polypeptides. In addition, the present invention provides methods for treatment of wounds with human skin equivalents engineered to express exogenous polypeptides.